Carcinoma: all 6,719 studies

Page 60 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• A Phase 1 Study in Participants With Advanced CancerCompletedNCT01115790Phase 1
• A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney CancerCompletedNCT01114230Phase 1
• Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast CancerCompletedNCT01112254Phase 3
• Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib TreatmentTerminatedNCT01108705Phase 3
• Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersCompletedNCT01107509Not applicable
• Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid CarcinomaCompletedNCT01103557Not applicable
• JAVLOR® Online Non-Interventional TrialCompletedNCT01103544
• Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCCTerminatedNCT01101906Phase 2
• Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerWithdrawnNCT01100489Phase 2
• Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese PatientsCompletedNCT01098760Phase 4
• Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerCompletedNCT01098630
• Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular CarcinomaTerminatedNCT01097083Phase 2
• Radiofrequency Versus Laser Ablation for Hepatocellular CarcinomaCompletedNCT01096914Not applicable
• Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal MetastasesWithdrawnNCT01095523Phase 2
• Prospective Multicentric Evaluation of a Bladder Preservation StrategyTerminatedNCT01093066Phase 2
• Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)CompletedNCT01092091Phase 1/2
• Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
• Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular CarcinomaCompletedNCT01088581Phase 3
• Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01086826Phase 3
• Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal CarcinomaStatus unknownNCT01086488Phase 2
• Sunitinib as Second-line Treatment in Advanced Biliary Tract CarcinomaCompletedNCT01082809Phase 2
• Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
• A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNCT01080066
• Human Papillomavirus (HPV) in Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01079546
• Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)CompletedNCT01078415Not applicable
• Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1
• Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.CompletedNCT01073839Phase 1/2
• Second-Line Docetaxel + ASA404 for Advanced Urothelial CarcinomaWithdrawnNCT01071928Phase 2
• RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryTerminatedNCT01071564Phase 1
• Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
• Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Status unknownNCT01069770Phase 2
• Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant AscitesCompletedNCT01065246Phase 2
• Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell CarcinomaCompletedNCT01064921Phase 1
• A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell CarcinomaTerminatedNCT01063998
• Efficacy of Ultrasound Contrast Agent to Assess Renal MassesCompletedNCT01062178Phase 2
• Study of MOC31-PE in Antigen Positive CarcinomasCompletedNCT01061645Phase 1
• Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal CancerActive, not recruitingNCT01061515Phase 1
• Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
• The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular CarcinomaStatus unknownNCT01055743Phase 2
• X-Ray Mammography Standard of Care ProtocolCompletedNCT01052740
• mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical TrialStatus unknownNCT01044420Phase 2
• Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
• A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaStatus unknownNCT01041482Phase 2
• Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular CarcinomasCompletedNCT01040559Phase 1
• A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
• Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer TherapyStatus unknownNCT01038258Not applicable
• Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular CancerCompletedNCT01034865
• Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal CarcinomaStatus unknownNCT01034683Phase 3
• Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisStatus unknownNCT01033578Not applicable
• AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
• Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell CarcinomaCompletedNCT01028638
• Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)Status unknownNCT01027676Phase 1/2
• Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT01026337
• Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxCompletedNCT01020097Not applicable
• Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C InfectionCompletedNCT01018381Not applicable
• Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsCompletedNCT01017185Phase 1
• Electronic Brachytherapy for the Treatment of NMSCCompletedNCT01016899
• Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct CarcinomaStatus unknownNCT01016002Phase 2
• A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell CarcinomaCompletedNCT01015911Phase 1
• Short Term Effects of Photodynamic Therapy in Basal Cell CarcinomaCompletedNCT01015898Phase 1
• Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
• A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)CompletedNCT01014065
• Merkel Positron Emission Tomography (PET) ProtocolCompletedNCT01013779Phase 2
• Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial CarcinomaCompletedNCT01013324Phase 2
• Regulatory Post Marketing Surveillance Study on Nexavar®CompletedNCT01012011
• Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
• Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
• Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular TechniqueCompletedNCT01008657Not applicable
• Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
• Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01008358Phase 2
• Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine NanoparticlesStatus unknownNCT01007240Phase 1
• Safety Study of BAY73-4506 in Patients With Hepatocellular CarcinomaCompletedNCT01003015Phase 2
• Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsCompletedNCT00999882Phase 1
• Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver CancerStatus unknownNCT00999843Phase 1/2
• A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the LungCompletedNCT00998192Phase 2
• Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal ChemotherapyCompletedNCT00997633
• Feasibility of Endoscopic Thyroidectomy for Thyroid CarcinomaStatus unknownNCT00993837Not applicable
• An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell CarcinomaCompletedNCT00992121Phase 1
• Study in Asia of the Combination of TACE With Sorafenib in HCC PatientsStatus unknownNCT00990860Phase 2
• Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
• Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNCT00988741Phase 2
• Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-upCompletedNCT00988455Phase 1/2
• Study of Pegylated Human Recombinant Arginase for Liver CancerCompletedNCT00988195Phase 1
• A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownNCT00986661Phase 1
• Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
• A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal CarcinomaStatus unknownNCT00973778Phase 2
• Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
• Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast CarcinomaCompletedNCT00970983Not applicable
• Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric CancerCompletedNCT00970138Phase 2/3
• Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCCompletedNCT00966472Phase 1
• Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular CarcinomaTerminatedNCT00966251Phase 1/2
• Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)CompletedNCT00963612Not applicable
• TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT00960518Phase 2
• A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)Status unknownNCT00960167Phase 1
• Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00958698Not applicable
• Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)CompletedNCT00956436Phase 1
• Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell CarcinomaTerminatedNCT00953446Not applicable
• Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T LymphocytesCompletedNCT00953420Phase 2
• Molecular Biology of Anal Cancer in HIV-Positive PatientsCompletedNCT00952874

← Carcinoma overview